NCT03001895View on ClinicalTrials.gov

Correlation Between SUV on 18F-DCFPyL PET/CT and Gleason Score in Prostate Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

October 5, 2018

Study Completion Date

October 5, 2018

Conditions
Prostate Cancer
Interventions
DRUG

18F-DCFPyL PET/CT

18F-DCFPyL PET/CT

Trial Locations (1)

H3T1E2

Jewish General Hospital, Montreal

All Listed Sponsors
lead

Sir Mortimer B. Davis - Jewish General Hospital

OTHER

NCT03001895 - Correlation Between SUV on 18F-DCFPyL PET/CT and Gleason Score in Prostate Cancer | Biotech Hunter | Biotech Hunter